MxT Biotech

Seoul, 
Korea (South)
https://mxtbiotech.com

MxT Biotech transforms genome editing, cancer immunotherapy, cellular engineering with our patented non-viral gene delivery platform, Hydroporator®. Hydroporator® is an an innovative microfluidic platform for engineering cells through highly efficient gene delivery, speeding up the discovery, development, and manufacturing of novel cell and gene therapies, and beyond.


 Products

  • Hydroporator®
    Hydroporator® is MxT Biotech's patented non-viral gene delivery platform, enabling the rapid delivery of biomolecules with high efficiency while preserving cell viability....

  • Hydroporator®
    Hydroporator® is MxT Biotech's patented non-viral gene delivery platform, enabling the rapid delivery of biomolecules with high efficiency while preserving cell viability....